Non-coding RNA-Associated ceRNA Networks in a New Contrast-Induced Acute Kidney Injury Rat Model-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Non-coding RNA-Associated ceRNA Networks in a New Contrast-Induced Acute Kidney Injury Rat Model

Published:2019-09 Issue: Volume:17 Page:102-112
ISSN:2162-2531
Container-title:Molecular Therapy - Nucleic Acids
language:en
Short-container-title:Molecular Therapy - Nucleic Acids

Author:

Cheng Wei,Li Xu-Wei,Xiao Ye-Qing,Duan Shao-Bin

Funder

National Natural Science Foundation of China

National Science and Technology Support Program of China

Publisher

Elsevier BV

Subject

Drug Discovery,Molecular Medicine

Reference61 articles.

1. Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1);Kellum;Crit. Care,2013

2. Contrast media and the kidney: European Society of Urogenital Radiology (ESUR) guidelines;Thomsen;Br. J. Radiol.,2003

3. Contrast-induced kidney injury: mechanisms, risk factors, and prevention;Seeliger;Eur. Heart J.,2012

4. Contrast-induced nephropathy: from pathophysiology to preventive strategies;Azzalini;Can. J. Cardiol.,2016

5. A new scoring model for the prediction of mortality in patients with acute kidney injury;Luo;Sci. Rep.,2017

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. LncRNA HILPDA promotes contrast-induced acute kidney injury by recruiting eIF4B to upregulate XPO1 expression;Toxicology Research;2024-07-01

2. A systematic review of epigenetic interplay in kidney diseases: Crosstalk between long noncoding RNAs and methylation, acetylation of chromatin and histone;Biomedicine & Pharmacotherapy;2024-07

3. Potential therapeutic applications of circular RNA in acute kidney injury;Biomedicine & Pharmacotherapy;2024-05

4. CircVMA21-related pathway alleviates lipopolysaccharide-induced HK-2 cell injury;Shock;2024-03-25

5. Combination of PARP inhibitor and CDK4/6 inhibitor modulates cGAS/STING‐dependent therapy‐induced senescence and provides “one‐two punch” opportunity with anti‐PD‐L1 therapy in colorectal cancer;Cancer Science;2023-09-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3